| D614G |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the aspartic acid at amino acid position 614 has been substituted with glycine has been detected in a sample. C179606 |
| N501Y |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the asparagine at amino acid position 501 has been substituted with tyrosine has been detected in a sample. C179608 |
| K417N/T |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the lysine at amino acid position 417 has been substituted with either asparagine or threonine has been detected in a sample. C179609 |
| E484K |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the glutamic acid at amino acid position 484 has been substituted with lysine has been detected in a sample. C179610 |
| P681H |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the proline at amino acid position 681 has been substituted with histidine has been detected in a sample. C179611 |
| 69/70 Deletion |
|
|
|
An indication that expression of SARS coronavirus 2 spike glycoprotein where the amino acids at positions 69 and 70 have been deleted has been detected in a sample. C179614 |
| Other, Specify |
|
|
|
A directive to specify when the listed responses are not sufficient. C157101 |